Answer
The selected product is licensed for PAH in children and adolescents aged 8 to under 18 years, under specialist care. Safety and effectiveness below age 8 have not been established.
Sources for this answer
- Ambrisentan 10 mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.